TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sundrug Co ( (JP:9989) ) has issued an update.
Sundrug Co., Ltd. has completed the payment for the disposal of 15,600 treasury shares as restricted stock compensation, a decision made during the Board of Directors’ meeting on June 20, 2025. This move is aimed at aligning the interests of its directors and executive officers with the company’s performance, potentially impacting its corporate governance and stakeholder relations.
The most recent analyst rating on (JP:9989) stock is a Buy with a Yen5400.00 price target. To see the full list of analyst forecasts on Sundrug Co stock, see the JP:9989 Stock Forecast page.
More about Sundrug Co
Sundrug Co., Ltd. operates in the retail industry, primarily focusing on pharmaceuticals and health-related products. It is listed on the Tokyo Stock Exchange, Prime Market, and is led by CEO Hiroshi Sadakata.
Average Trading Volume: 342,788
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen537.6B
For an in-depth examination of 9989 stock, go to TipRanks’ Overview page.